Skip to main content
OpenTrials
Completed

NCT Number: NCT04522401

Performance Evaluation Platform for Seniors.

Monocentric prospective non-randomized observational study with subgroup analysis on the assessment of the day hospital at the Aging Biennial Hospital of Saint-Etienne.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre Hospitalier Universitaire de Saint-Etienne

Saint-Etienne, 42270, France

About this study

Monocentric prospective non-randomized observational study with subgroup analysis on the assessment of the day hospital at the Aging Biennial Hospital of Saint-Etienne.

The main objective is to investigate the factors limiting or encouraging adherence to recommendations in a population aged over 65, fragile or pre-fragile, autonomous and living at home or in a shelter.

Patients will benefit from a multidisciplinary assessment including a geriatric assessment standardized by a geriatrician, an evaluation by a dietician, an evaluation by an occupational therapist. They will then be exposed to a personalized plan of care in the form of a recommendation.

Patients will be followed at home to evaluate the implementation of their personalized care plan at 3 months of their assessment day at the day hospital, then at 6 and 9 months. The study will take place over a period of approximately 24 months.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Person affiliated or entitled to a social security scheme
  • People aged 65 and over who participated in a consultation to age well at the day hospital of the St-Etienne university hospital during the study period.
  • Elderly people who received an information about the study and who co-signed, with the investigator, a consent to participate in the study

Exclusion criteria

  • Seniors who refused to participate
  • Elderly people under legal protection measures
  • Severe cognitive impairment

Treatment and study plan

consultation: "Bien vieillir"

Diagnostic Test

Patients will benefit from a multidisciplinary assessment including a geriatric assessment standardized by a geriatrician, an evaluation by a dietician, an evaluation by an occupational therapist. They will then be exposed to a personalized plan of care in the form of a recommendation.Then, patients will be followed at home to evaluate the implementation of their personalized care plan at 3 months of their assessment day, then at 6 and 9 months.

Primary outcomes

  1. rate of implementation of recommendations concerning mobility (adapted physical activity).

    Time frame: Months: 9

    This rate is the ratio between the number of mobility recommendations made at 9 months and the number initially recommended.

    Analysis by tracking sheet patient results.

Secondary outcomes

  1. Overall rate of implementation of the recommendations at 9 months

    Time frame: Months: 9

    Analysis by tracking sheet patient results.

  2. Satisfaction rate of the platform's users

    Time frame: Months: 9

    Analysis by qualitative interviews results.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne

Other

Registry information

Official study title

Prevention of the Loss of Autonomy in the Old People: Factors Favoring or Limiting the Respect of Recommendations

Acronym: PEPS

Important dates

Study start
2018
Primary completion
2019
Study completion
2020
First posted
Aug 21, 2020
Registry last updated
Nov 13, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.